Ginsenoside Rg2 Delays Brain Aging Via Inhibiting Α-Synuclein Expression And Promoting Foxo-Mediated Neurogenesis In Mice
As we age, our brains naturally undergo changes that can affect memory and thinking. A key player in this process is a protein called α-synuclein. Recent research suggests that elevated levels of α-synuclein can act as an “accelerator” of brain aging, specifically by hindering the brain’s ability to produce new neurons, a process known as neurogenesis.
Neurogenesis, the creation of new brain cells, is vital for maintaining cognitive functions like learning and memory. This process is partly regulated by a pathway involving a protein called FoxO1. When α-synuclein levels are high, it can disrupt this FoxO1-mediated neurogenesis, leading to a decline in brain health.
However, a promising compound derived from ginseng, known as ginsenoside Rg2, has shown potential in counteracting these effects. Studies in aging mice revealed that treatment with this compound significantly reduced the expression of α-synuclein. By doing so, it helped to decrease markers of oxidative stress and aging, while simultaneously boosting the creation of new brain cells through the FoxO1 pathway.
The mice treated with this ginseng compound also demonstrated improved cognitive function. These findings suggest that this natural compound could offer a novel approach to mitigating brain aging and cognitive decline by targeting the harmful effects of α-synuclein and promoting the brain’s regenerative capabilities.
Source: link to paper